Clinical Trial Update: Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of PT003, PT005, and PT001 in moderate to very severe chronic obstructive pulmonary disease has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PT001
• PT003
• PT005

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-02-20